# REMEVi reviews (2026): GLP-1 telehealth sellers | This GLP The advertised rates belong to a fifty-two week plan, and the site promises no titration hikes. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/remevi Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Fifty-two weeks, not twelve months # REMEVi review The advertised rates belong to a fifty-two week plan, and the site promises no titration hikes. ## The verdict REMEVi publishes $199 a month for compounded semaglutide and $269 for tirzepatide on a 52-week plan. Month to month is $279 and $339. Coverage is 51 jurisdictions. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection States 51 From From $279/mo Prescription Required Compounded Yes — not FDA-approved Availability 51 jurisdictions REMEVi sells both molecules by injection. Two plan lengths are priced. The site states the price does not rise with titration. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. The pages state plans and terms. The clinician is not described. Two commitments are published rather than one, which lets a reader price either path. The claim of no titration hikes is a real promise and it applies to both. 2. ## What happens when the dose goes up? The site states the same price every month with no [titration](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) hikes. That answers the question directly. Nothing describes clinical support at a dose increase. 3. ## What the price includes Six months month to month is $1,674 on semaglutide. The 52-week plan is $199, so a year is $2,388 against $3,348 paid monthly. The saving is $80 a month on semaglutide and $70 on tirzepatide, for a year of commitment. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named. ## Where it holds up, and where it does not - Strength: No titration hikes, stated plainly - Strength: Both plan lengths published - Strength: Coverage in 51 jurisdictions - Limitation: The headline needs 52 weeks - Limitation: Month to month costs $80 more - Limitation: No compounding pharmacy is named ## What the evidence says about this kind of treatment The assessment above is about REMEVi. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader committing a year who wants the rate fixed through titration. Wrong for A reader paying month to month from the advertised figure. ## The evidence behind what REMEVi prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How REMEVi compares | Seller | Who it suits | Go | | --- | --- | --- | | Rejuve Meds | Readers who will prepay a year and have read the footnote under the label | | | Renlo Health | Readers who want the flat claim shown at each tier rather than asserted once | | | Rewinding RX | Readers who want a fixed figure and the doses it covers listed | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Garcia Weight Loss, Aesthetics & Hormone Therapy](https://thisglp.com/reviews/garcia-weight-loss) [Gaya Wellness](https://thisglp.com/reviews/gaya-wellness) [Genesis Health](https://thisglp.com/reviews/genesis) [Get Thin MD](https://thisglp.com/reviews/get-thin-md) [GetRelief Rx](https://thisglp.com/reviews/getrelief-rx) [Gimme Care](https://thisglp.com/reviews/gimme-care) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is $199 a monthly rate? It belongs to the 52-week plan. Month to month is $279. Does the price rise as my dose goes up? No. The site states the same price every month with no titration hikes. Where does REMEVi ship? Fifty-one jurisdictions are recorded. Is REMEVi legit? REMEVi is a GLP-1 telehealth sellers service. Its stated availability: 51 jurisdictions. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is REMEVi expensive compared with other GLP-1 telehealth sellers? REMEVi publishes a starting figure of $279/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts REMEVi above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).